NanoViricides (NNVC) Tops Q3 EPS by 5c

NanoViricides (NYSE: NNVC) reported Q3 EPS of ($0.14), $0.05 better than the analyst estimate of ($0.19).

For earnings history and earnings-related data on NanoViricides (NNVC) click here.

You May Also Be Interested In

• Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
• Nuvve Holdin (NVVE) Misses Q2 EPS by 1445c
• H.C. Wainwright Reiterates Buy Rating on Tvardi Therapeutics Inc (TVRD)